China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective cohort study on skeletal and muscular system changes in patients with prim... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of an Anesthesiology-Led Preoperative Coordinated Assessment Pathway on Perioper... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Medication adherence and its correlates among glaucoma patients: a cross-sectional study... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Randomized, Open-Label, Phase II Trial Comparing Neoadjuvant Tislelizumab... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Differential Molecular Mechanisms Underlying Early Phenotypic Remodeling Driven by Genet... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Retrospective Study of Bone Formation Outcomes After Maxillary Sinus Lateral Approach ... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Prospective, Exploratory Controlled Study on the Safety and Effectiveness... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluate the relationship between early orthodontic treatment with the Twin-block applia... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Single-Arm, Phase II Window-of-Opportunity Clinical Study of Dalpicicli... Read More
China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of tofacitinib at different doses in the treatment of adult moderate... Read More